Convalescent Plasma (CP) Transfusion as Prophylactic Treatment for COVID-19
Convalescent plasma (filtered plasma containing antibodies from recovered individuals) is a treatment option with ongoing research. It can be used as treatment for severely ill patients or as prophylaxis for highly susceptible individuals. While many patients show marked improvement in symptoms, studies involving CP also include other treatment, so the sole effectiveness of CP transfusion is yet unclear. Recovered individuals are encouraged to donate their plasma for research and recovery.
0
4
Contributors are:
Who are from:
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Journal References for COVID-19 Papers on Resuscitation
Resuscitation and Associated Outcomes in COVID-19 Patients in Wuhan, China
References for COVID-19 Papers on CP Transfusion by Journal/Source
Convalescent Plasma (CP) Transfusion as Prophylactic Treatment for COVID-19
Convalescent Plasma (CP) Transfusion as Prophylactic Treatment for COVID-19
Hydroxychloroquine as Prophylactic Treatment for COVID-19
Genetic Engineering in Vaccine Development for COVID-19
Umifenovir (Arbidol) as Prophylactic Treatment for COVID-19
Prescribing Prebiotics and Probiotics as a Prophylactic Treatment for Groups at-risk of COVID-19